nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—colon cancer	0.406	0.515	CiPCiCtD
Clofarabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—colon cancer	0.381	0.485	CiPCiCtD
Clofarabine—ABCG2—Irinotecan—colon cancer	0.0319	0.297	CbGbCtD
Clofarabine—ABCG2—Fluorouracil—colon cancer	0.0306	0.285	CbGbCtD
Clofarabine—ABCG2—Vincristine—colon cancer	0.0279	0.26	CbGbCtD
Clofarabine—ABCG2—Methotrexate—colon cancer	0.0169	0.157	CbGbCtD
Clofarabine—RRM2—embryo—colon cancer	0.00121	0.0699	CbGeAlD
Clofarabine—ABCG2—Abacavir transmembrane transport—ABCB1—colon cancer	0.000982	0.0384	CbGpPWpGaD
Clofarabine—RRM2—G1/S-Specific Transcription—TYMS—colon cancer	0.000969	0.0379	CbGpPWpGaD
Clofarabine—RRM2—renal system—colon cancer	0.000917	0.0529	CbGeAlD
Clofarabine—RRM1—smooth muscle tissue—colon cancer	0.000791	0.0457	CbGeAlD
Clofarabine—DCK—embryo—colon cancer	0.000782	0.0451	CbGeAlD
Clofarabine—RRM1—renal system—colon cancer	0.000762	0.044	CbGeAlD
Clofarabine—RRM2—lymphoid tissue—colon cancer	0.000761	0.0439	CbGeAlD
Clofarabine—RRM2—digestive system—colon cancer	0.000752	0.0434	CbGeAlD
Clofarabine—DCK—Topotecan—Irinotecan—colon cancer	0.000732	0.393	CbGdCrCtD
Clofarabine—POLA1—bone marrow—colon cancer	0.000726	0.0419	CbGeAlD
Clofarabine—POLA1—vagina—colon cancer	0.000695	0.0401	CbGeAlD
Clofarabine—RRM2—bone marrow—colon cancer	0.000693	0.04	CbGeAlD
Clofarabine—RRM1—Fluoropyrimidine Activity—TYMS—colon cancer	0.000692	0.0271	CbGpPWpGaD
Clofarabine—DCK—Pyrimidine metabolism—TYMS—colon cancer	0.000687	0.0269	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.000669	0.0262	CbGpPWpGaD
Clofarabine—RRM2—vagina—colon cancer	0.000664	0.0383	CbGeAlD
Clofarabine—POLA1—G1/S-Specific Transcription—TYMS—colon cancer	0.000663	0.0259	CbGpPWpGaD
Clofarabine—RRM1—lymphoid tissue—colon cancer	0.000633	0.0365	CbGeAlD
Clofarabine—RRM1—digestive system—colon cancer	0.000625	0.0361	CbGeAlD
Clofarabine—POLA1—liver—colon cancer	0.000587	0.0338	CbGeAlD
Clofarabine—RRM2—Vinorelbine—Vincristine—colon cancer	0.000582	0.312	CbGdCrCtD
Clofarabine—RRM1—bone marrow—colon cancer	0.000576	0.0332	CbGeAlD
Clofarabine—RRM2—E2F mediated regulation of DNA replication—TYMS—colon cancer	0.00057	0.0223	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—TYMS—colon cancer	0.00057	0.0223	CbGpPWpGaD
Clofarabine—ABCG2—Abacavir transport and metabolism—ABCB1—colon cancer	0.000564	0.0221	CbGpPWpGaD
Clofarabine—RRM2—liver—colon cancer	0.00056	0.0323	CbGeAlD
Clofarabine—RRM1—vagina—colon cancer	0.000552	0.0318	CbGeAlD
Clofarabine—POLA1—Vinblastine—Vincristine—colon cancer	0.000551	0.295	CbGdCrCtD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.000551	0.0215	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.000515	0.0201	CbGpPWpGaD
Clofarabine—DCK—lymphoid tissue—colon cancer	0.000491	0.0284	CbGeAlD
Clofarabine—DCK—digestive system—colon cancer	0.000485	0.028	CbGeAlD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000483	0.0189	CbGpPWpGaD
Clofarabine—RRM1—liver—colon cancer	0.000466	0.0269	CbGeAlD
Clofarabine—POLA1—lymph node—colon cancer	0.00045	0.026	CbGeAlD
Clofarabine—DCK—bone marrow—colon cancer	0.000447	0.0258	CbGeAlD
Clofarabine—RRM2—lymph node—colon cancer	0.00043	0.0248	CbGeAlD
Clofarabine—DCK—vagina—colon cancer	0.000429	0.0247	CbGeAlD
Clofarabine—POLA1—E2F mediated regulation of DNA replication—TYMS—colon cancer	0.00039	0.0152	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.000377	0.0147	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—TYMS—colon cancer	0.000367	0.0143	CbGpPWpGaD
Clofarabine—DCK—liver—colon cancer	0.000362	0.0209	CbGeAlD
Clofarabine—RRM1—lymph node—colon cancer	0.000357	0.0206	CbGeAlD
Clofarabine—RRM1—Nucleotide metabolism—TYMS—colon cancer	0.000348	0.0136	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000329	0.0129	CbGpPWpGaD
Clofarabine—Adenosine monophosphate—SRC—colon cancer	0.000319	1	CrCbGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TYMS—colon cancer	0.000319	0.0125	CbGpPWpGaD
Clofarabine—ABCG2—Irinotecan Pathway—APC—colon cancer	0.000311	0.0122	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—TYMS—colon cancer	0.000302	0.0118	CbGpPWpGaD
Clofarabine—RRM2—Nucleotide metabolism—TYMS—colon cancer	0.000287	0.0112	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000277	0.0108	CbGpPWpGaD
Clofarabine—DCK—lymph node—colon cancer	0.000277	0.016	CbGeAlD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.000272	0.0106	CbGpPWpGaD
Clofarabine—DCK—Nucleotide metabolism—TYMS—colon cancer	0.000268	0.0105	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TYMS—colon cancer	0.000263	0.0103	CbGpPWpGaD
Clofarabine—ABCG2—bone marrow—colon cancer	0.00025	0.0144	CbGeAlD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—colon cancer	0.000245	0.00959	CbGpPWpGaD
Clofarabine—ABCG2—vagina—colon cancer	0.000239	0.0138	CbGeAlD
Clofarabine—RRM1—Fluoropyrimidine Activity—TP53—colon cancer	0.00023	0.00898	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000222	0.00867	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—TYMS—colon cancer	0.000219	0.00857	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TYMS—colon cancer	0.000213	0.00834	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MLH3—colon cancer	0.000211	0.00825	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—TYMS—colon cancer	0.000207	0.00808	CbGpPWpGaD
Clofarabine—ABCG2—liver—colon cancer	0.000202	0.0116	CbGeAlD
Clofarabine—RRM1—Metabolism—CA7—colon cancer	0.000201	0.00786	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.0002	0.00781	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—TP53—colon cancer	0.000189	0.00739	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.000186	0.00725	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—TYMS—colon cancer	0.000185	0.00722	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—colon cancer	0.00018	0.00702	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—CDKN1A—colon cancer	0.000179	0.00699	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000173	0.00677	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—EP300—colon cancer	0.00017	0.00665	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.00017	0.00665	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CA7—colon cancer	0.000166	0.00647	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000164	0.0064	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	0.000161	0.00628	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—colon cancer	0.000158	0.00619	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000156	0.00611	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	0.000155	0.00607	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CA7—colon cancer	0.000155	0.00605	CbGpPWpGaD
Clofarabine—ABCG2—lymph node—colon cancer	0.000155	0.00893	CbGeAlD
Clofarabine—POLA1—G1/S Transition—TYMS—colon cancer	0.00015	0.00586	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—MYC—colon cancer	0.000148	0.00579	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—CDKN1A—colon cancer	0.000147	0.00575	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MLH3—colon cancer	0.000144	0.00565	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—EP300—colon cancer	0.00014	0.00547	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	0.000132	0.00517	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—colon cancer	0.000129	0.00503	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	0.000128	0.005	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—TYMS—colon cancer	0.000126	0.00494	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.000125	0.00488	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000125	0.00488	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—ABCB1—colon cancer	0.000125	0.00488	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	0.000124	0.00483	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—MYC—colon cancer	0.000122	0.00477	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CHST5—colon cancer	0.000122	0.00476	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ODC1—colon cancer	0.000122	0.00476	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	0.00012	0.00467	CbGpPWpGaD
Clofarabine—Angiopathy—Irinotecan—colon cancer	0.000119	0.00196	CcSEcCtD
Clofarabine—Blood creatinine increased—Capecitabine—colon cancer	0.000118	0.00196	CcSEcCtD
Clofarabine—Immune system disorder—Irinotecan—colon cancer	0.000118	0.00195	CcSEcCtD
Clofarabine—Mediastinal disorder—Irinotecan—colon cancer	0.000118	0.00195	CcSEcCtD
Clofarabine—Dehydration—Capecitabine—colon cancer	0.000118	0.00195	CcSEcCtD
Clofarabine—Mental disorder—Vincristine—colon cancer	0.000118	0.00194	CcSEcCtD
Clofarabine—Chills—Irinotecan—colon cancer	0.000117	0.00194	CcSEcCtD
Clofarabine—Neoplasm—Methotrexate—colon cancer	0.000117	0.00194	CcSEcCtD
Clofarabine—Mouth ulceration—Methotrexate—colon cancer	0.000117	0.00194	CcSEcCtD
Clofarabine—Dry skin—Capecitabine—colon cancer	0.000116	0.00192	CcSEcCtD
Clofarabine—Alopecia—Irinotecan—colon cancer	0.000115	0.00191	CcSEcCtD
Clofarabine—Abdominal pain upper—Capecitabine—colon cancer	0.000115	0.00191	CcSEcCtD
Clofarabine—Pulmonary oedema—Methotrexate—colon cancer	0.000115	0.00191	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000114	0.00188	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000114	0.00188	CcSEcCtD
Clofarabine—Back pain—Vincristine—colon cancer	0.000113	0.00187	CcSEcCtD
Clofarabine—Sepsis—Methotrexate—colon cancer	0.000112	0.00186	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000111	0.00184	CcSEcCtD
Clofarabine—Alopecia—Fluorouracil—colon cancer	0.000111	0.00183	CcSEcCtD
Clofarabine—Back pain—Irinotecan—colon cancer	0.00011	0.00182	CcSEcCtD
Clofarabine—Influenza—Capecitabine—colon cancer	0.000109	0.00181	CcSEcCtD
Clofarabine—Erythema—Fluorouracil—colon cancer	0.000109	0.0018	CcSEcCtD
Clofarabine—Anaemia—Vincristine—colon cancer	0.000108	0.00179	CcSEcCtD
Clofarabine—Agitation—Vincristine—colon cancer	0.000107	0.00178	CcSEcCtD
Clofarabine—RRM2—G1/S Transition—CDKN1A—colon cancer	0.000107	0.00418	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MYC—colon cancer	0.000106	0.00415	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—colon cancer	0.000106	0.00413	CbGpPWpGaD
Clofarabine—Anaemia—Irinotecan—colon cancer	0.000105	0.00174	CcSEcCtD
Clofarabine—Leukopenia—Vincristine—colon cancer	0.000105	0.00173	CcSEcCtD
Clofarabine—Pancytopenia—Capecitabine—colon cancer	0.000104	0.00172	CcSEcCtD
Clofarabine—Neutropenia—Capecitabine—colon cancer	0.000102	0.00169	CcSEcCtD
Clofarabine—Renal failure acute—Methotrexate—colon cancer	0.000102	0.00169	CcSEcCtD
Clofarabine—Leukopenia—Irinotecan—colon cancer	0.000102	0.00168	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Capecitabine—colon cancer	0.000102	0.00168	CcSEcCtD
Clofarabine—Hypertension—Vincristine—colon cancer	0.000101	0.00167	CcSEcCtD
Clofarabine—Anaemia—Fluorouracil—colon cancer	0.000101	0.00167	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—CDKN1A—colon cancer	0.000101	0.00394	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ODC1—colon cancer	0.0001	0.00392	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CHST5—colon cancer	0.0001	0.00392	CbGpPWpGaD
Clofarabine—Myalgia—Vincristine—colon cancer	9.94e-05	0.00165	CcSEcCtD
Clofarabine—Cough—Irinotecan—colon cancer	9.92e-05	0.00164	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—colon cancer	9.91e-05	0.00387	CbGpPWpGaD
Clofarabine—Weight decreased—Capecitabine—colon cancer	9.88e-05	0.00164	CcSEcCtD
Clofarabine—Hypertension—Irinotecan—colon cancer	9.82e-05	0.00162	CcSEcCtD
Clofarabine—Pneumonia—Capecitabine—colon cancer	9.8e-05	0.00162	CcSEcCtD
Clofarabine—Leukopenia—Fluorouracil—colon cancer	9.75e-05	0.00161	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	9.75e-05	0.00381	CbGpPWpGaD
Clofarabine—Infestation NOS—Capecitabine—colon cancer	9.74e-05	0.00161	CcSEcCtD
Clofarabine—Infestation—Capecitabine—colon cancer	9.74e-05	0.00161	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Capecitabine—colon cancer	9.66e-05	0.0016	CcSEcCtD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—EP300—colon cancer	9.65e-05	0.00377	CbGpPWpGaD
Clofarabine—Lethargy—Methotrexate—colon cancer	9.6e-05	0.00159	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—EP300—colon cancer	9.58e-05	0.00374	CbGpPWpGaD
Clofarabine—Renal failure—Capecitabine—colon cancer	9.58e-05	0.00158	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	9.57e-05	0.00374	CbGpPWpGaD
Clofarabine—Neuropathy peripheral—Capecitabine—colon cancer	9.55e-05	0.00158	CcSEcCtD
Clofarabine—Oedema—Vincristine—colon cancer	9.53e-05	0.00158	CcSEcCtD
Clofarabine—Jaundice—Capecitabine—colon cancer	9.49e-05	0.00157	CcSEcCtD
Clofarabine—Stomatitis—Capecitabine—colon cancer	9.49e-05	0.00157	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	9.47e-05	0.0037	CbGpPWpGaD
Clofarabine—Infection—Vincristine—colon cancer	9.47e-05	0.00157	CcSEcCtD
Clofarabine—DCK—Metabolism—CHST5—colon cancer	9.37e-05	0.00366	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ODC1—colon cancer	9.37e-05	0.00366	CbGpPWpGaD
Clofarabine—Nervous system disorder—Vincristine—colon cancer	9.35e-05	0.00155	CcSEcCtD
Clofarabine—Thrombocytopenia—Vincristine—colon cancer	9.33e-05	0.00154	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CCND1—colon cancer	9.3e-05	0.00364	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MLH1—colon cancer	9.29e-05	0.00363	CbGpPWpGaD
Clofarabine—Haematuria—Capecitabine—colon cancer	9.29e-05	0.00154	CcSEcCtD
Clofarabine—Oedema—Irinotecan—colon cancer	9.28e-05	0.00154	CcSEcCtD
Clofarabine—Myalgia—Fluorouracil—colon cancer	9.27e-05	0.00153	CcSEcCtD
Clofarabine—Infection—Irinotecan—colon cancer	9.22e-05	0.00153	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	9.22e-05	0.00361	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Vincristine—colon cancer	9.21e-05	0.00152	CcSEcCtD
Clofarabine—Hepatobiliary disease—Capecitabine—colon cancer	9.21e-05	0.00152	CcSEcCtD
Clofarabine—Epistaxis—Capecitabine—colon cancer	9.19e-05	0.00152	CcSEcCtD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—colon cancer	9.14e-05	0.00357	CbGpPWpGaD
Clofarabine—Nervous system disorder—Irinotecan—colon cancer	9.1e-05	0.00151	CcSEcCtD
Clofarabine—Thrombocytopenia—Irinotecan—colon cancer	9.09e-05	0.0015	CcSEcCtD
Clofarabine—Anorexia—Vincristine—colon cancer	9.09e-05	0.0015	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	9.04e-05	0.00354	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN1A—colon cancer	9e-05	0.00352	CbGpPWpGaD
Clofarabine—Irritability—Methotrexate—colon cancer	8.98e-05	0.00149	CcSEcCtD
Clofarabine—Hyperhidrosis—Irinotecan—colon cancer	8.97e-05	0.00148	CcSEcCtD
Clofarabine—Hypotension—Vincristine—colon cancer	8.91e-05	0.00147	CcSEcCtD
Clofarabine—Oedema—Fluorouracil—colon cancer	8.89e-05	0.00147	CcSEcCtD
Clofarabine—RRM2—G1/S Transition—MYC—colon cancer	8.85e-05	0.00346	CbGpPWpGaD
Clofarabine—Anorexia—Irinotecan—colon cancer	8.85e-05	0.00146	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—BUB1B—colon cancer	8.84e-05	0.00346	CbGpPWpGaD
Clofarabine—Infection—Fluorouracil—colon cancer	8.83e-05	0.00146	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	8.79e-05	0.00344	CbGpPWpGaD
Clofarabine—Haemoglobin—Capecitabine—colon cancer	8.79e-05	0.00145	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	8.75e-05	0.00342	CbGpPWpGaD
Clofarabine—Haemorrhage—Capecitabine—colon cancer	8.74e-05	0.00145	CcSEcCtD
Clofarabine—Nervous system disorder—Fluorouracil—colon cancer	8.72e-05	0.00144	CcSEcCtD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—colon cancer	8.71e-05	0.0034	CbGpPWpGaD
Clofarabine—Thrombocytopenia—Fluorouracil—colon cancer	8.7e-05	0.00144	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Vincristine—colon cancer	8.68e-05	0.00144	CcSEcCtD
Clofarabine—Tachycardia—Fluorouracil—colon cancer	8.68e-05	0.00144	CcSEcCtD
Clofarabine—Hypotension—Irinotecan—colon cancer	8.67e-05	0.00144	CcSEcCtD
Clofarabine—Urinary tract disorder—Capecitabine—colon cancer	8.64e-05	0.00143	CcSEcCtD
Clofarabine—Oedema peripheral—Capecitabine—colon cancer	8.61e-05	0.00143	CcSEcCtD
Clofarabine—Connective tissue disorder—Capecitabine—colon cancer	8.59e-05	0.00142	CcSEcCtD
Clofarabine—Urethral disorder—Capecitabine—colon cancer	8.57e-05	0.00142	CcSEcCtD
Clofarabine—Paraesthesia—Vincristine—colon cancer	8.56e-05	0.00142	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	8.56e-05	0.00335	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	8.47e-05	0.00331	CbGpPWpGaD
Clofarabine—Anorexia—Fluorouracil—colon cancer	8.47e-05	0.0014	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Methotrexate—colon cancer	8.47e-05	0.0014	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—MYC—colon cancer	8.35e-05	0.00326	CbGpPWpGaD
Clofarabine—Paraesthesia—Irinotecan—colon cancer	8.33e-05	0.00138	CcSEcCtD
Clofarabine—Hypotension—Fluorouracil—colon cancer	8.31e-05	0.00137	CcSEcCtD
Clofarabine—Decreased appetite—Vincristine—colon cancer	8.29e-05	0.00137	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	8.28e-05	0.00324	CbGpPWpGaD
Clofarabine—Dyspnoea—Irinotecan—colon cancer	8.28e-05	0.00137	CcSEcCtD
Clofarabine—Erythema multiforme—Capecitabine—colon cancer	8.27e-05	0.00137	CcSEcCtD
Clofarabine—Somnolence—Irinotecan—colon cancer	8.25e-05	0.00137	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Vincristine—colon cancer	8.23e-05	0.00136	CcSEcCtD
Clofarabine—Fatigue—Vincristine—colon cancer	8.22e-05	0.00136	CcSEcCtD
Clofarabine—Pain—Vincristine—colon cancer	8.15e-05	0.00135	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—colon cancer	8.14e-05	0.00318	CbGpPWpGaD
Clofarabine—Cardiac disorder—Capecitabine—colon cancer	8.12e-05	0.00134	CcSEcCtD
Clofarabine—Flushing—Capecitabine—colon cancer	8.12e-05	0.00134	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Fluorouracil—colon cancer	8.1e-05	0.00134	CcSEcCtD
Clofarabine—POLA1—Synthesis of DNA—CDKN1A—colon cancer	8.08e-05	0.00316	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—BUB1B—colon cancer	8.08e-05	0.00316	CbGpPWpGaD
Clofarabine—Decreased appetite—Irinotecan—colon cancer	8.07e-05	0.00134	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Irinotecan—colon cancer	8.01e-05	0.00133	CcSEcCtD
Clofarabine—Fatigue—Irinotecan—colon cancer	8e-05	0.00132	CcSEcCtD
Clofarabine—Paraesthesia—Fluorouracil—colon cancer	7.98e-05	0.00132	CcSEcCtD
Clofarabine—Pancreatitis—Methotrexate—colon cancer	7.97e-05	0.00132	CcSEcCtD
Clofarabine—Pain—Irinotecan—colon cancer	7.94e-05	0.00131	CcSEcCtD
Clofarabine—Angiopathy—Capecitabine—colon cancer	7.93e-05	0.00131	CcSEcCtD
Clofarabine—Dyspnoea—Fluorouracil—colon cancer	7.93e-05	0.00131	CcSEcCtD
Clofarabine—Somnolence—Fluorouracil—colon cancer	7.9e-05	0.00131	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—BUB1B—colon cancer	7.9e-05	0.00309	CbGpPWpGaD
Clofarabine—Immune system disorder—Capecitabine—colon cancer	7.9e-05	0.00131	CcSEcCtD
Clofarabine—Mediastinal disorder—Capecitabine—colon cancer	7.88e-05	0.0013	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	7.88e-05	0.00308	CbGpPWpGaD
Clofarabine—Chills—Capecitabine—colon cancer	7.85e-05	0.0013	CcSEcCtD
Clofarabine—Gastrointestinal pain—Vincristine—colon cancer	7.79e-05	0.00129	CcSEcCtD
Clofarabine—Decreased appetite—Fluorouracil—colon cancer	7.73e-05	0.00128	CcSEcCtD
Clofarabine—Alopecia—Capecitabine—colon cancer	7.73e-05	0.00128	CcSEcCtD
Clofarabine—Pancytopenia—Methotrexate—colon cancer	7.72e-05	0.00128	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Fluorouracil—colon cancer	7.68e-05	0.00127	CcSEcCtD
Clofarabine—Mental disorder—Capecitabine—colon cancer	7.66e-05	0.00127	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	7.66e-05	0.00299	CbGpPWpGaD
Clofarabine—Feeling abnormal—Irinotecan—colon cancer	7.65e-05	0.00127	CcSEcCtD
Clofarabine—Malnutrition—Capecitabine—colon cancer	7.61e-05	0.00126	CcSEcCtD
Clofarabine—Erythema—Capecitabine—colon cancer	7.61e-05	0.00126	CcSEcCtD
Clofarabine—Neutropenia—Methotrexate—colon cancer	7.6e-05	0.00126	CcSEcCtD
Clofarabine—Pain—Fluorouracil—colon cancer	7.6e-05	0.00126	CcSEcCtD
Clofarabine—Gastrointestinal pain—Irinotecan—colon cancer	7.59e-05	0.00126	CcSEcCtD
Clofarabine—POLA1—DNA Replication—CDKN1A—colon cancer	7.58e-05	0.00296	CbGpPWpGaD
Clofarabine—Upper respiratory tract infection—Methotrexate—colon cancer	7.56e-05	0.00125	CcSEcCtD
Clofarabine—Abdominal pain—Vincristine—colon cancer	7.53e-05	0.00125	CcSEcCtD
Clofarabine—Body temperature increased—Vincristine—colon cancer	7.53e-05	0.00125	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—MYC—colon cancer	7.46e-05	0.00292	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	7.46e-05	0.00292	CbGpPWpGaD
Clofarabine—Back pain—Capecitabine—colon cancer	7.36e-05	0.00122	CcSEcCtD
Clofarabine—Body temperature increased—Irinotecan—colon cancer	7.34e-05	0.00121	CcSEcCtD
Clofarabine—Abdominal pain—Irinotecan—colon cancer	7.34e-05	0.00121	CcSEcCtD
Clofarabine—Feeling abnormal—Fluorouracil—colon cancer	7.33e-05	0.00121	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—CDKN1A—colon cancer	7.3e-05	0.00286	CbGpPWpGaD
Clofarabine—Pneumonia—Methotrexate—colon cancer	7.29e-05	0.00121	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—colon cancer	7.25e-05	0.00284	CbGpPWpGaD
Clofarabine—Infestation—Methotrexate—colon cancer	7.25e-05	0.0012	CcSEcCtD
Clofarabine—Infestation NOS—Methotrexate—colon cancer	7.25e-05	0.0012	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Methotrexate—colon cancer	7.19e-05	0.00119	CcSEcCtD
Clofarabine—Tremor—Capecitabine—colon cancer	7.13e-05	0.00118	CcSEcCtD
Clofarabine—Renal failure—Methotrexate—colon cancer	7.13e-05	0.00118	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—colon cancer	7.07e-05	0.00277	CbGpPWpGaD
Clofarabine—Stomatitis—Methotrexate—colon cancer	7.07e-05	0.00117	CcSEcCtD
Clofarabine—Anaemia—Capecitabine—colon cancer	7.04e-05	0.00116	CcSEcCtD
Clofarabine—Body temperature increased—Fluorouracil—colon cancer	7.03e-05	0.00116	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	7.03e-05	0.00275	CbGpPWpGaD
Clofarabine—Hypersensitivity—Vincristine—colon cancer	7.02e-05	0.00116	CcSEcCtD
Clofarabine—Haematuria—Methotrexate—colon cancer	6.91e-05	0.00114	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	6.86e-05	0.00268	CbGpPWpGaD
Clofarabine—Hepatobiliary disease—Methotrexate—colon cancer	6.86e-05	0.00113	CcSEcCtD
Clofarabine—POLA1—S Phase—CCND1—colon cancer	6.85e-05	0.00268	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	6.85e-05	0.00268	CbGpPWpGaD
Clofarabine—Epistaxis—Methotrexate—colon cancer	6.84e-05	0.00113	CcSEcCtD
Clofarabine—Hypersensitivity—Irinotecan—colon cancer	6.84e-05	0.00113	CcSEcCtD
Clofarabine—Asthenia—Vincristine—colon cancer	6.84e-05	0.00113	CcSEcCtD
Clofarabine—Leukopenia—Capecitabine—colon cancer	6.81e-05	0.00113	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—TYMS—colon cancer	6.78e-05	0.00265	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	6.71e-05	0.00263	CbGpPWpGaD
Clofarabine—Asthenia—Irinotecan—colon cancer	6.66e-05	0.0011	CcSEcCtD
Clofarabine—Cough—Capecitabine—colon cancer	6.64e-05	0.0011	CcSEcCtD
Clofarabine—POLA1—S Phase—CDKN1A—colon cancer	6.63e-05	0.00259	CbGpPWpGaD
Clofarabine—Hypertension—Capecitabine—colon cancer	6.57e-05	0.00109	CcSEcCtD
Clofarabine—Hypersensitivity—Fluorouracil—colon cancer	6.55e-05	0.00108	CcSEcCtD
Clofarabine—Haemoglobin—Methotrexate—colon cancer	6.54e-05	0.00108	CcSEcCtD
Clofarabine—Diarrhoea—Vincristine—colon cancer	6.52e-05	0.00108	CcSEcCtD
Clofarabine—Haemorrhage—Methotrexate—colon cancer	6.51e-05	0.00108	CcSEcCtD
Clofarabine—Myalgia—Capecitabine—colon cancer	6.48e-05	0.00107	CcSEcCtD
Clofarabine—Arthralgia—Capecitabine—colon cancer	6.48e-05	0.00107	CcSEcCtD
Clofarabine—Anxiety—Capecitabine—colon cancer	6.46e-05	0.00107	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	6.44e-05	0.00106	CcSEcCtD
Clofarabine—Urinary tract disorder—Methotrexate—colon cancer	6.43e-05	0.00106	CcSEcCtD
Clofarabine—Urethral disorder—Methotrexate—colon cancer	6.38e-05	0.00106	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCND1—colon cancer	6.36e-05	0.00249	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MLH1—colon cancer	6.36e-05	0.00249	CbGpPWpGaD
Clofarabine—Diarrhoea—Irinotecan—colon cancer	6.35e-05	0.00105	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	6.34e-05	0.00248	CbGpPWpGaD
Clofarabine—Dizziness—Vincristine—colon cancer	6.3e-05	0.00104	CcSEcCtD
Clofarabine—Pruritus—Fluorouracil—colon cancer	6.29e-05	0.00104	CcSEcCtD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	6.28e-05	0.00245	CbGpPWpGaD
Clofarabine—Oedema—Capecitabine—colon cancer	6.21e-05	0.00103	CcSEcCtD
Clofarabine—ABCG2—Metabolism—CA7—colon cancer	6.19e-05	0.00242	CbGpPWpGaD
Clofarabine—Infection—Capecitabine—colon cancer	6.17e-05	0.00102	CcSEcCtD
Clofarabine—Erythema multiforme—Methotrexate—colon cancer	6.15e-05	0.00102	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—colon cancer	6.15e-05	0.00241	CbGpPWpGaD
Clofarabine—Dizziness—Irinotecan—colon cancer	6.14e-05	0.00102	CcSEcCtD
Clofarabine—Nervous system disorder—Capecitabine—colon cancer	6.09e-05	0.00101	CcSEcCtD
Clofarabine—Diarrhoea—Fluorouracil—colon cancer	6.08e-05	0.00101	CcSEcCtD
Clofarabine—Thrombocytopenia—Capecitabine—colon cancer	6.08e-05	0.00101	CcSEcCtD
Clofarabine—Tachycardia—Capecitabine—colon cancer	6.06e-05	0.001	CcSEcCtD
Clofarabine—Vomiting—Vincristine—colon cancer	6.06e-05	0.001	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—TYMS—colon cancer	6.06e-05	0.00237	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—MYC—colon cancer	6.06e-05	0.00237	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—BUB1B—colon cancer	6.04e-05	0.00236	CbGpPWpGaD
Clofarabine—Cardiac disorder—Methotrexate—colon cancer	6.04e-05	0.001	CcSEcCtD
Clofarabine—Skin disorder—Capecitabine—colon cancer	6.03e-05	0.000999	CcSEcCtD
Clofarabine—Rash—Vincristine—colon cancer	6.01e-05	0.000994	CcSEcCtD
Clofarabine—Hyperhidrosis—Capecitabine—colon cancer	6.01e-05	0.000994	CcSEcCtD
Clofarabine—Dermatitis—Vincristine—colon cancer	6e-05	0.000994	CcSEcCtD
Clofarabine—Headache—Vincristine—colon cancer	5.97e-05	0.000988	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—colon cancer	5.96e-05	0.00233	CbGpPWpGaD
Clofarabine—Anorexia—Capecitabine—colon cancer	5.92e-05	0.00098	CcSEcCtD
Clofarabine—Angiopathy—Methotrexate—colon cancer	5.91e-05	0.000977	CcSEcCtD
Clofarabine—Vomiting—Irinotecan—colon cancer	5.9e-05	0.000977	CcSEcCtD
Clofarabine—Immune system disorder—Methotrexate—colon cancer	5.88e-05	0.000973	CcSEcCtD
Clofarabine—Dizziness—Fluorouracil—colon cancer	5.88e-05	0.000973	CcSEcCtD
Clofarabine—Mediastinal disorder—Methotrexate—colon cancer	5.87e-05	0.000971	CcSEcCtD
Clofarabine—Rash—Irinotecan—colon cancer	5.85e-05	0.000968	CcSEcCtD
Clofarabine—Dermatitis—Irinotecan—colon cancer	5.85e-05	0.000968	CcSEcCtD
Clofarabine—Chills—Methotrexate—colon cancer	5.84e-05	0.000966	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	5.83e-05	0.00228	CbGpPWpGaD
Clofarabine—Headache—Irinotecan—colon cancer	5.81e-05	0.000962	CcSEcCtD
Clofarabine—Hypotension—Capecitabine—colon cancer	5.81e-05	0.000961	CcSEcCtD
Clofarabine—Alopecia—Methotrexate—colon cancer	5.75e-05	0.000952	CcSEcCtD
Clofarabine—Mental disorder—Methotrexate—colon cancer	5.7e-05	0.000944	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—EP300—colon cancer	5.68e-05	0.00222	CbGpPWpGaD
Clofarabine—Erythema—Methotrexate—colon cancer	5.67e-05	0.000938	CcSEcCtD
Clofarabine—Malnutrition—Methotrexate—colon cancer	5.67e-05	0.000938	CcSEcCtD
Clofarabine—Nausea—Vincristine—colon cancer	5.66e-05	0.000937	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Capecitabine—colon cancer	5.66e-05	0.000937	CcSEcCtD
Clofarabine—Vomiting—Fluorouracil—colon cancer	5.65e-05	0.000935	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	5.64e-05	0.0022	CbGpPWpGaD
Clofarabine—Rash—Fluorouracil—colon cancer	5.61e-05	0.000928	CcSEcCtD
Clofarabine—Dermatitis—Fluorouracil—colon cancer	5.6e-05	0.000927	CcSEcCtD
Clofarabine—Paraesthesia—Capecitabine—colon cancer	5.58e-05	0.000923	CcSEcCtD
Clofarabine—Headache—Fluorouracil—colon cancer	5.57e-05	0.000922	CcSEcCtD
Clofarabine—Dyspnoea—Capecitabine—colon cancer	5.54e-05	0.000916	CcSEcCtD
Clofarabine—Nausea—Irinotecan—colon cancer	5.51e-05	0.000912	CcSEcCtD
Clofarabine—POLA1—S Phase—MYC—colon cancer	5.5e-05	0.00215	CbGpPWpGaD
Clofarabine—Back pain—Methotrexate—colon cancer	5.48e-05	0.000907	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—BUB1B—colon cancer	5.4e-05	0.00211	CbGpPWpGaD
Clofarabine—Decreased appetite—Capecitabine—colon cancer	5.4e-05	0.000894	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	5.38e-05	0.0021	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Capecitabine—colon cancer	5.36e-05	0.000888	CcSEcCtD
Clofarabine—Fatigue—Capecitabine—colon cancer	5.36e-05	0.000886	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	5.33e-05	0.00209	CbGpPWpGaD
Clofarabine—Pain—Capecitabine—colon cancer	5.31e-05	0.000879	CcSEcCtD
Clofarabine—Nausea—Fluorouracil—colon cancer	5.28e-05	0.000874	CcSEcCtD
Clofarabine—Anaemia—Methotrexate—colon cancer	5.24e-05	0.000867	CcSEcCtD
Clofarabine—Feeling abnormal—Capecitabine—colon cancer	5.12e-05	0.000847	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—MYC—colon cancer	5.1e-05	0.002	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Capecitabine—colon cancer	5.08e-05	0.000841	CcSEcCtD
Clofarabine—Leukopenia—Methotrexate—colon cancer	5.07e-05	0.000839	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	4.95e-05	0.00194	CbGpPWpGaD
Clofarabine—Cough—Methotrexate—colon cancer	4.94e-05	0.000818	CcSEcCtD
Clofarabine—Abdominal pain—Capecitabine—colon cancer	4.91e-05	0.000813	CcSEcCtD
Clofarabine—Body temperature increased—Capecitabine—colon cancer	4.91e-05	0.000813	CcSEcCtD
Clofarabine—Arthralgia—Methotrexate—colon cancer	4.82e-05	0.000798	CcSEcCtD
Clofarabine—Myalgia—Methotrexate—colon cancer	4.82e-05	0.000798	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	4.82e-05	0.00188	CbGpPWpGaD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	4.79e-05	0.000793	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	4.77e-05	0.00187	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	4.76e-05	0.00186	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	4.66e-05	0.00182	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—TYMS—colon cancer	4.63e-05	0.00181	CbGpPWpGaD
Clofarabine—Infection—Methotrexate—colon cancer	4.59e-05	0.00076	CcSEcCtD
Clofarabine—Hypersensitivity—Capecitabine—colon cancer	4.58e-05	0.000757	CcSEcCtD
Clofarabine—Nervous system disorder—Methotrexate—colon cancer	4.54e-05	0.00075	CcSEcCtD
Clofarabine—Thrombocytopenia—Methotrexate—colon cancer	4.53e-05	0.000749	CcSEcCtD
Clofarabine—Skin disorder—Methotrexate—colon cancer	4.49e-05	0.000743	CcSEcCtD
Clofarabine—Hyperhidrosis—Methotrexate—colon cancer	4.47e-05	0.00074	CcSEcCtD
Clofarabine—Asthenia—Capecitabine—colon cancer	4.46e-05	0.000738	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	4.44e-05	0.00173	CbGpPWpGaD
Clofarabine—Anorexia—Methotrexate—colon cancer	4.41e-05	0.000729	CcSEcCtD
Clofarabine—Pruritus—Capecitabine—colon cancer	4.4e-05	0.000727	CcSEcCtD
Clofarabine—Hypotension—Methotrexate—colon cancer	4.32e-05	0.000715	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	4.31e-05	0.00169	CbGpPWpGaD
Clofarabine—Diarrhoea—Capecitabine—colon cancer	4.25e-05	0.000703	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Methotrexate—colon cancer	4.21e-05	0.000697	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	4.2e-05	0.00164	CbGpPWpGaD
Clofarabine—Paraesthesia—Methotrexate—colon cancer	4.15e-05	0.000687	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—TYMS—colon cancer	4.14e-05	0.00162	CbGpPWpGaD
Clofarabine—Dyspnoea—Methotrexate—colon cancer	4.12e-05	0.000682	CcSEcCtD
Clofarabine—Somnolence—Methotrexate—colon cancer	4.11e-05	0.00068	CcSEcCtD
Clofarabine—Dizziness—Capecitabine—colon cancer	4.11e-05	0.00068	CcSEcCtD
Clofarabine—Decreased appetite—Methotrexate—colon cancer	4.02e-05	0.000665	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Methotrexate—colon cancer	3.99e-05	0.000661	CcSEcCtD
Clofarabine—Fatigue—Methotrexate—colon cancer	3.99e-05	0.00066	CcSEcCtD
Clofarabine—Pain—Methotrexate—colon cancer	3.95e-05	0.000654	CcSEcCtD
Clofarabine—Vomiting—Capecitabine—colon cancer	3.95e-05	0.000654	CcSEcCtD
Clofarabine—Rash—Capecitabine—colon cancer	3.92e-05	0.000648	CcSEcCtD
Clofarabine—Dermatitis—Capecitabine—colon cancer	3.91e-05	0.000648	CcSEcCtD
Clofarabine—Headache—Capecitabine—colon cancer	3.89e-05	0.000644	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	3.87e-05	0.00151	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	3.86e-05	0.00151	CbGpPWpGaD
Clofarabine—Feeling abnormal—Methotrexate—colon cancer	3.81e-05	0.000631	CcSEcCtD
Clofarabine—Gastrointestinal pain—Methotrexate—colon cancer	3.78e-05	0.000626	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	3.78e-05	0.00148	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CHST5—colon cancer	3.75e-05	0.00147	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ODC1—colon cancer	3.75e-05	0.00147	CbGpPWpGaD
Clofarabine—Nausea—Capecitabine—colon cancer	3.69e-05	0.000611	CcSEcCtD
Clofarabine—Abdominal pain—Methotrexate—colon cancer	3.66e-05	0.000605	CcSEcCtD
Clofarabine—Body temperature increased—Methotrexate—colon cancer	3.66e-05	0.000605	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	3.57e-05	0.0014	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	3.43e-05	0.00134	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND1—colon cancer	3.41e-05	0.00133	CbGpPWpGaD
Clofarabine—Hypersensitivity—Methotrexate—colon cancer	3.41e-05	0.000564	CcSEcCtD
Clofarabine—Asthenia—Methotrexate—colon cancer	3.32e-05	0.000549	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1A—colon cancer	3.3e-05	0.00129	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	3.28e-05	0.00128	CbGpPWpGaD
Clofarabine—Pruritus—Methotrexate—colon cancer	3.27e-05	0.000541	CcSEcCtD
Clofarabine—RRM1—Metabolism—ABCB1—colon cancer	3.22e-05	0.00126	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	3.18e-05	0.00124	CbGpPWpGaD
Clofarabine—Diarrhoea—Methotrexate—colon cancer	3.16e-05	0.000524	CcSEcCtD
Clofarabine—RRM1—Metabolism—TYMS—colon cancer	3.16e-05	0.00124	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—EP300—colon cancer	3.14e-05	0.00123	CbGpPWpGaD
Clofarabine—Dizziness—Methotrexate—colon cancer	3.06e-05	0.000506	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CCND1—colon cancer	3.05e-05	0.00119	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1A—colon cancer	2.95e-05	0.00115	CbGpPWpGaD
Clofarabine—Vomiting—Methotrexate—colon cancer	2.94e-05	0.000487	CcSEcCtD
Clofarabine—Rash—Methotrexate—colon cancer	2.92e-05	0.000483	CcSEcCtD
Clofarabine—Dermatitis—Methotrexate—colon cancer	2.91e-05	0.000482	CcSEcCtD
Clofarabine—Headache—Methotrexate—colon cancer	2.9e-05	0.000479	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—EP300—colon cancer	2.81e-05	0.0011	CbGpPWpGaD
Clofarabine—Nausea—Methotrexate—colon cancer	2.75e-05	0.000455	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—colon cancer	2.74e-05	0.00107	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	2.68e-05	0.00105	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ABCB1—colon cancer	2.65e-05	0.00104	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—TYMS—colon cancer	2.6e-05	0.00102	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ABCB1—colon cancer	2.48e-05	0.000968	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MYC—colon cancer	2.45e-05	0.000957	CbGpPWpGaD
Clofarabine—DCK—Metabolism—TYMS—colon cancer	2.43e-05	0.000951	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND1—colon cancer	2.33e-05	0.000912	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—colon cancer	2.26e-05	0.000883	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PPARG—colon cancer	2.24e-05	0.000875	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—EP300—colon cancer	2.15e-05	0.00084	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.12e-05	0.000827	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND1—colon cancer	2.09e-05	0.000816	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1A—colon cancer	2.02e-05	0.000789	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—colon cancer	2.01e-05	0.000786	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—EP300—colon cancer	1.92e-05	0.000751	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—colon cancer	1.87e-05	0.000732	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPARG—colon cancer	1.84e-05	0.000721	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS2—colon cancer	1.76e-05	0.000689	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPARG—colon cancer	1.72e-05	0.000674	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYC—colon cancer	1.67e-05	0.000654	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—EP300—colon cancer	1.46e-05	0.000573	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS2—colon cancer	1.45e-05	0.000567	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—colon cancer	1.37e-05	0.000537	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS2—colon cancer	1.36e-05	0.00053	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—EP300—colon cancer	1.21e-05	0.000472	CbGpPWpGaD
Clofarabine—DCK—Metabolism—EP300—colon cancer	1.13e-05	0.000441	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CA—colon cancer	1.08e-05	0.000424	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCB1—colon cancer	9.91e-06	0.000388	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TYMS—colon cancer	9.73e-06	0.000381	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CA—colon cancer	8.92e-06	0.000349	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—colon cancer	8.85e-06	0.000346	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CA—colon cancer	8.34e-06	0.000326	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—colon cancer	7.29e-06	0.000285	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPARG—colon cancer	6.9e-06	0.00027	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—colon cancer	6.81e-06	0.000266	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS2—colon cancer	5.42e-06	0.000212	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—EP300—colon cancer	4.51e-06	0.000176	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CA—colon cancer	3.34e-06	0.00013	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—colon cancer	2.73e-06	0.000107	CbGpPWpGaD
